Analystreport

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report